IVF vs SENS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 06, 2026

IVF

24.4
AI Score
VS
SENS Wins

SENS

45.6
AI Score

Investment Advisor Scores

IVF

24score
Recommendation
SELL

SENS

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IVF SENS Winner
Revenue 1.64M 26.19M SENS
Net Income -17.40M -69.04M IVF
Net Margin -1063.0% -263.6% SENS
Operating Income -1.20M -67.83M IVF
ROE 64.0% -76.4% IVF
ROA -54.8% -39.0% SENS
Total Assets 31.74M 176.84M SENS
Cash 840,407 44.75M SENS
Current Ratio 0.08 6.74 SENS
Free Cash Flow -3.56M -62.49M IVF

Relative Price Performance (Last 90 Days)

IVF 1M: +320.4% · 3M: +177.3% SENS 1M: +16.8% · 3M: +34.8%

Current Technical Phase

IVF

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.3% over 20 days), RSI 88

RSI (14): 87.9 · Price: $2.69

SENS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.6% over 20 days), RSI 63

RSI (14): 62.5 · Price: $10.42

Fundamentals Snapshot

Metric IVF SENS
Market Cap — —
Forward P/E -0.1 -5.5
Trailing P/E 0.0 —
Revenue (TTM) — —
Revenue Growth 0.2% 1.4%
Gross Margin 0.4% 0.6%
Operating Margin -0.6% -1.6%
EPS 511.80 -2.27
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, SENS is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.